Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An open label, balanced, randomized, three-treatment, three-period, six-sequence, cross-over, single dose, comparative bioavailability pilot study of two test formulations of fixed dose combination capsules of acetylsalicylic acid (ASA) and pantoprazole (Each capsule contains ASA 100 mg and pantoprazole 20 mg) manufactured by Piramal Healthcare Limited, India for GSK comparing with Aspirin® Protect 100 mg tablets by Bayer vital GmbH, and Protium® 20 mg gastro-resistant tablets by Nycomed GmbH, in healthy, adult, human subjects, under fed conditions
acetylsalicylic acid/pantoprazole
APP116498
NCT01847417
Ulcers, Duodenal and Gastric
Phase 1
 
An analysis-ready dataset is not available for this study. An annotated case report form is not available for this study. A blank case report form will be provided.
May 2017

Powered by ideaPoint, Inc.